InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Foose Brice. Director active across 1 company, notably Invivo Therapeutics Holdings CORP.. In total, 2 reports have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €21k. History available since 5 February 2023. The latest transaction was disclosed on 5 February 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条